P. Roger

819 total citations
23 papers, 170 citations indexed

About

P. Roger is a scholar working on Infectious Diseases, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, P. Roger has authored 23 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in P. Roger's work include Pituitary Gland Disorders and Treatments (4 papers), Antibiotic Use and Resistance (3 papers) and HIV Research and Treatment (2 papers). P. Roger is often cited by papers focused on Pituitary Gland Disorders and Treatments (4 papers), Antibiotic Use and Resistance (3 papers) and HIV Research and Treatment (2 papers). P. Roger collaborates with scholars based in France, Guadeloupe and Morocco. P. Roger's co-authors include P. Dellamonica, Élisa Demonchy, Antoine Tabarin, Éric Cua, Christian Pradier, Amy Bernard, P. Puglièse, C. Pulcini, E Bernard and Karine Risso and has published in prestigious journals such as PLoS ONE, European Journal of Endocrinology and Clinical & Experimental Immunology.

In The Last Decade

P. Roger

19 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Roger France 7 69 58 53 52 25 23 170
Alice Rosenberg United States 6 91 1.3× 20 0.3× 55 1.0× 43 0.8× 124 5.0× 6 205
Sarah Moore Canada 9 176 2.6× 27 0.5× 86 1.6× 145 2.8× 60 2.4× 17 322
S Léautez Canada 7 67 1.0× 31 0.5× 10 0.2× 36 0.7× 24 1.0× 17 115
Livia Giner Spain 8 81 1.2× 77 1.3× 13 0.2× 69 1.3× 71 2.8× 13 191
Yann Quertainmont France 7 85 1.2× 114 2.0× 16 0.3× 35 0.7× 37 1.5× 14 200
Kirk A. Ryan United States 10 43 0.6× 63 1.1× 11 0.2× 12 0.2× 12 0.5× 24 248
Marcelo Costa Velho Mendes de Azevedo Brazil 7 49 0.7× 48 0.8× 18 0.3× 27 0.5× 20 0.8× 22 139
Serges Tchatchouang Cameroon 8 49 0.7× 69 1.2× 23 0.4× 8 0.2× 6 0.2× 17 143
P C K Li China 4 169 2.4× 50 0.9× 9 0.2× 35 0.7× 9 0.4× 4 241
G. Gutiérrez Spain 6 22 0.3× 32 0.6× 39 0.7× 12 0.2× 43 1.7× 6 176

Countries citing papers authored by P. Roger

Since Specialization
Citations

This map shows the geographic impact of P. Roger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Roger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Roger more than expected).

Fields of papers citing papers by P. Roger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Roger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Roger. The network helps show where P. Roger may publish in the future.

Co-authorship network of co-authors of P. Roger

This figure shows the co-authorship network connecting the top 25 collaborators of P. Roger. A scholar is included among the top collaborators of P. Roger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Roger. P. Roger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ouissa, Rachida, et al.. (2022). Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use. Infectious Diseases Now. 52(3). 145–148. 3 indexed citations
2.
Roger, P., et al.. (2021). Infections chez les patients transplantés rénaux : perspectives Antillaises. Infectious Diseases Now. 51(5). S35–S35.
3.
Lieutier, F., et al.. (2018). Politique institutionnelle de bon usage des antibiotiques : ne pas oublier les anciennes molécules ! Exemple des fluoroquinolones. Médecine et Maladies Infectieuses. 48(4). S61–S61. 1 indexed citations
4.
Assi, Ayman, et al.. (2018). Utilisation combinée des protocoles d’antibiothérapies et des antibiogrammes ciblés pour le bon usage des antibiotiques. Médecine et Maladies Infectieuses. 48(4). S51–S52. 2 indexed citations
5.
Sakarovitch, Charlotte, J. Durant, Karine Risso, et al.. (2015). Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study. PLoS ONE. 10(10). e0140519–e0140519. 23 indexed citations
7.
Chirio, David, Élisa Demonchy, P. Roger, et al.. (2014). Syndrome de Parsonage Turner et hépatite E : à propos de deux cas. La Revue de Médecine Interne. 35. A124–A124. 1 indexed citations
8.
Demonchy, Élisa, P. Dellamonica, P. Roger, et al.. (2011). Audit of antibiotic therapy used in 66 cases of endocarditis. Médecine et Maladies Infectieuses. 41(11). 602–607. 25 indexed citations
9.
Roger, P., et al.. (2008). J-09 Évaluation prospective des associations d’antibiotiques par l’infectiologue référent d’un centre hospitalier. Médecine et Maladies Infectieuses. 38. S159–S159. 1 indexed citations
10.
Roger, P., et al.. (2001). Bilan médical d’une unité d’hospitalisation ouverte pendant l’épidémie de grippe de l’hiver 1999–2000. La Revue de Médecine Interne. 22(5). 433–439. 6 indexed citations
11.
Vandenbos, F., et al.. (2000). Aspergillose cérébrale et cryptococcose neuroméningée chez un patient atteint du sida. Médecine et Maladies Infectieuses. 30(7). 474–476. 2 indexed citations
12.
Sassolas, G., I Bachelot, P. Chanson, et al.. (1999). GH deficiency in adults: an epidemiological approach. European Journal of Endocrinology. 141(6). 595–600. 29 indexed citations
13.
Roger, P., et al.. (1999). LES RECHERCHES A L'IRD SUR LA DEPOLLUTION ET LA VALORISATION DE DECHETS AGRICOLES ET. 1 indexed citations
14.
Gin, H., Bogdan Catargi, Vincent Rigalleau, et al.. (1998). Experience with the Biostator for diagnosis and assisted surgery of 21 insulinomas. European Journal of Endocrinology. 139(4). 371–377. 12 indexed citations
15.
Ginot, Vincent, Yves Souchon, & P. Roger. (1996). Impact de l'élévation artificielle de température induite par le fonctionnement du Centre Nucléaire de Production Electrique du Bugey(fleuve Rhône) sur les communautés de poissons. Springer Link (Chiba Institute of Technology). 8. 1–33. 8 indexed citations
16.
Roger, P., et al.. (1996). [Cushing's disease: role of feeding].. PubMed. 25(29). 1326–30. 1 indexed citations
17.
Tabarin, Antoine & P. Roger. (1994). [Cushing's syndrome: diagnostic exploration].. PubMed. 23(1). 43–8. 8 indexed citations
18.
Tabarin, Antoine, et al.. (1992). [Biological and developmental aspects of macronodular adrenal hyperplasia in Cushing's disease].. PubMed. 53(2). 59–66. 3 indexed citations
19.
Leprat, F, et al.. (1991). [Macronodule associated with bilateral adrenal hyperplasia. A rare misleading cause of primary aldosteronism (two cases)].. PubMed. 20(19). 899–902. 2 indexed citations
20.
Lefort, G., et al.. (1981). [The utilization of small repeated doses of iodine 131 in the treatment of Graves' disease. Results (author's transl)].. PubMed. 41(6). 601–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026